Literature DB >> 15252886

[Comparative study of life quality in patients with cycloid and schizophrenic psychoses].

B Jabs1, U Krause, G Althaus, G Stöber, B Pfuhlmann.   

Abstract

BACKGROUND: Cycloid psychoses represent a nosological entity not adequately recognised by contemporary psychiatry. They show full recovery after each episode and thus have a favourable prognosis.
METHODS: Course, psychiatric status, social function, and quality of life (QoL) of 33 patients with cycloid psychosis and 44 schizophrenics were compared (CGI, PANSS, GAF, Strauss-Carpenter,WHOQOL-BREF).Also, 48 controls were asked to rate their QoL.
RESULTS: The schizophrenics developed symptoms earlier in life (P=0.009) and were hospitalized longer (P=0.001) and more frequently(P=0.01) than patients with cycloid psychosis. The latter showed better scores in the applied scales (P<0.0001). In QoL measures, cycloid psychotic patients were more satisfied than schizophrenic patients in three of four domains(P<0.01). Only in one domain did they differ from controls (P<0.01).
CONCLUSION: Cycloid psychoses display better course, outcome, and QoL than schizophrenia.Thus, they appear to present a useful concept deserving more clinical and scientific attention.

Entities:  

Mesh:

Year:  2004        PMID: 15252886     DOI: 10.1007/s00115-003-1591-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  19 in total

1.  Quality of life in the evaluation of community support systems.

Authors:  F Baker; J Intagliata
Journal:  Eval Program Plann       Date:  1982

2.  Quality of life and mental illness. Reflections from the perspective of the WHOQOL.

Authors:  J Orley; S Saxena; H Herrman
Journal:  Br J Psychiatry       Date:  1998-04       Impact factor: 9.319

3.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

4.  Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine.

Authors:  C A Galletly; C R Clark; A C McFarlane; D L Weber
Journal:  Psychiatry Res       Date:  1997-10-10       Impact factor: 3.222

5.  Psychopathology and quality of life in schizophrenia.

Authors:  S Packer; J Husted; S Cohen; G Tomlinson
Journal:  J Psychiatry Neurosci       Date:  1997-07       Impact factor: 6.186

6.  [The analysis of the cost structures of the treatment of schizophrenia by means of standardized assessment instruments].

Authors:  R Kilian; C Roick; H Matschinger; S Bernert; C Mory; M C Angermeyer
Journal:  Psychiatr Prax       Date:  2001-10

7.  A 10-year followup of remitting schizophrenics.

Authors:  G E Vaillant
Journal:  Schizophr Bull       Date:  1978       Impact factor: 9.306

Review 8.  [Schizophrenia and age].

Authors:  H Häfner; K Maurer; W Löffler; A Riecher-Rössler
Journal:  Nervenarzt       Date:  1991-09       Impact factor: 1.214

9.  Premorbid adjustment as predictor of outcome in schizophrenia: results of a prospective study.

Authors:  J Bailer; W Bräuer; E R Rey
Journal:  Acta Psychiatr Scand       Date:  1996-05       Impact factor: 6.392

10.  Gender and the course of schizophrenia: differences in treated outcomes.

Authors:  M C Angermeyer; L Kühn; J M Goldstein
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.